Hai F. Qian
No. 198, Hongqi Road
Huzhou, 313000, China
Huzhou, 313000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 210 publications
Selective Visualization of ROR1-Positive TNBC of the Mesenchymal-Like Subtype Using Peptide-Based 68Ga-PET Radiotracers.
Journal: Journal of medicinal chemistry
Published: June 29, 2026
Spatial transcriptomics reveals injury-responsive compartments and coordinated immune-fibrotic signaling in ANCA-associated renal vasculitis.
Journal: Frontiers in immunology
Published: May 18, 2026
Peptide-Based ROR1-Targeting PET Ligands for Melanoma Tumor Imaging: Design and Preclinical Evaluation.
Journal: Journal of medicinal chemistry
Published: March 23, 2026
Antagonists of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) as rationale and therapeutic potential of combination cancer therapy.
Journal: American journal of clinical and experimental immunology
Published: March 15, 2026
Structure-guided discovery of phenyl-carbamates as novel dual TRPV1 antagonists/FAAH inhibitors.
Journal: Bioorganic chemistry
Published: March 13, 2026
Role of CDX2 in the prognosis of colorectal cancer across stages 0-IV.
Journal: Oncology letters
Published: December 19, 2025
Discovery of Novel Potent and Safe Immunoproteasome Inhibitors with Bridged Ring for Anti-Inflammatory Therapy.
Journal: Journal of medicinal chemistry
Published: November 10, 2025
V-domain immunoglobulin suppressor of T-cell activation regulates CD4+ T cell activation and podocyte function through PI3K/AKT signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 07, 2025
Call for Papers: Pharmaceutical Innovation and Global Health: Breakthroughs and Future─Celebrating the 90th Anniversary of China Pharmaceutical University.
Journal: Journal of medicinal chemistry
Published: September 24, 2025
A dual-responsive AI-designed peptide P9-conjugate disrupts E6-E6AP Interface to restore p53 and suppress HPV16-driven cervical cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 18, 2025
Optimization of novel TRPV1 antagonists bearing 1-((2,2-difluorobenzo[d][1,3] dioxol-5-yl) methyl) piperazine for pain management: Mechanistic insights into NLRP3 Inflammasome modulation.
Journal: Bioorganic & medicinal chemistry
Published: August 26, 2025
Single-nucleus analysis reveals human-specific oligodendrocyte polarization and conserved neuronal responses after severe traumatic brain injury.
Journal: Nature communications
Published: August 11, 2025
Last Updated: 09/26/2026